More than 5 million Americans are currently affected by Alzheimer's disease (AD) and that number is expected to triple by 2050 (Alzheimer's Association, 2017). Approaches to AD care are increasingly focused on identifying individuals at heightened risk for the disease and providing risk estimates based on evidence of cognitive impairment, family history, genetic information, and biomarkers (e.g., amyloid neuroimaging results, genetic variants) (Sperling et al., 2011) . APOE is a susceptibility polymorphism for late-onset AD, which is the most common form of AD and the most common dementia in the aging population. APOE has three alleles: ε2, ε3, and ε4, and each person has two alleles. Hundreds of studies have demonstrated the well-documented association of APOE genotype with risk of AD in which 1 copy of the APOE ε4 allele increases the odds of developing disease by~3-fold and 2 copies increase the odds by~12-15-fold (Bertram, McQueen, Mullin, Blacker, & Tanzi, 2007; Farrer et al., 1997) . Approximately, a quarter of the general population in the United States carries the risk-conferring APOE ε4 allele (Raber, Huang, & Ashford, 2004) . For many older adults, disease risk-whether for AD or other medical disorders-is communicated in both clinical and research settings. However, the abstract and complex nature of probabilistic information conveyed during AD risk disclosure discussions can be cognitively and emotionally challenging for anyone, and especially so for patients with impaired memory (Roberts, Christensen, & Green, 2011) .
Older patients are frequently accompanied to medical visits by family members or friends and companions have been shown to play an important and largely positive role in facilitating physician-patient communication (Street & Gordon, 2008; Wolff & Roter, 2008 , 2011 . Estimates from the Medicare Current Beneficiary Survey showed that 40% of older adults are routinely accompanied to their medical visits and that they report higher satisfaction with physician information-giving and rapport-building when accompanied by a companion (Wolff & Roter, 2011) . Older adults also tend to be more satisfied when accompanied by more engaged family companions.
A similar process appears evident in medical visits of patients with AD. In their analysis of 23 routine AD primary care visits, Schmidt and colleagues found that cognitive impairment was associated with diminished patient contribution but greater family member participation in visit dialog. Moreover, the more verbally active the family member was, the more satisfied patients were with the visit (Schmidt, Lingler, & Schulz, 2009) .
The current study makes a contribution to this literature by analyzing audio recordings and survey data of 79 AD risk disclosure sessions with patients who have diagnoses of mild cognitive impairment (MCI) and a visit companion. The session communication was coded and examined in relation to both patient and companion postsession satisfaction. Based on the previous research on physician-patient communication broadly, and specifically in regard to older adults as noted above (Schmidt et al., 2009; Street & Gordon, 2008 , 2011 Wolff & Roter, 2008 , 2011 , we hypothesized that a more patient-centered communication style would receive higher satisfaction ratings from both patients and companions. We also hypothesized that companions' communication behaviors would be associated with patient satisfaction.
Methods

Study Design and Data Collection
Analyses were based on audio recordings of AD risk disclosure sessions collected as part of the fourth independent trial of the REVEAL Study. This randomized clinical trial was designed to evaluate the impact of AD risk communication, conveyed with and without results of genotype (identification of the presence of ε4 allele in APOE gene), to patients with MCI diagnoses and their visit companions. Patients were eligible for recruitment if they had clinical diagnoses of amnestic-MCI, defined at the time of the study as a clinical state where individuals are memory impaired but are functionally intact and do not meet clinical criteria for dementia (Petersen et al., 2001) . The specific criteria are (1) a memory complaint, corroborated by an informant; (2) abnormal memory function, as documented by delayed recall on the Logical Memory II subtest of the Wechsler Memory Scale-Revised; (3) adequate general cognitive function (Mini-Mental State Examination [MMSE] score ≥20); and (4) no diagnosis of AD and no or minimal impairment in activities of daily living. Study design, recruitment, and data collection of the fourth REVEAL Study have been described in detail elsewhere (Guan et al., 2017) . The sample for the current study included 79 AD risk disclosure sessions conducted by 3 genetic counselors; patients were randomly assigned at a 2:1 ratio to either an APOE genotype disclosure group (N = 54) or APOE genotype nondisclosure group (N = 25). Patients assigned to the genotype nondisclosure group received 3-year risk estimates for conversion to AD based on their age and the diagnosis of MCI. Patients in the genotype disclosure group were given risk estimates based on the same factors in conjunction with their APOE genotype. MCI patients with one or two ε4 alleles are at increased risk of developing AD (Petersen et al., 2005) . The current study was reviewed and approved by the Johns Hopkins University Bloomberg School of Public Health Institutional Review Board, as well as institutional review boards at each study site.
Patient and Companion Satisfaction with Provider Communication
The primary study outcomes were patient and companion satisfaction with the AD risk disclosure session administered immediately after sessions ended. The 10-item satisfaction questionnaire was developed by Roter and colleagues in previous genetic counseling studies (Roter, Ellington, Erby, Larson, & Dudley, 2006) and adapted to AD risk disclosure (e.g., "your clinician was able to explain the Alzheimer's disease risk estimate and its meaning in a way that you could understand" and "your clinician acted supportive and gave you the feeling that he/she was a partner with you"). Patients and companions were asked to rate their satisfaction about the communication process using a Likert scale of "strongly disagree = 1" to "strongly agree = 5." Because satisfaction scores were negatively skewed, we created a dichotomous variable "high satisfaction" to compare the highest ranking category (highly satisfied; total satisfaction score = 50) with all other responses for both patients and companions. The scales demonstrated strong internal consistency (Cronbach's alpha = 0.88 and 0.90 for patient and companion satisfaction scales, respectively).
Roter Interaction Analysis System
Audio recordings of risk disclosure dialog were coded using Roter Interaction Analysis System (RIAS), a widely used quantitative coding system for medical dialog that has demonstrated high reliability and predictive validity for patient satisfaction, utilization, and adherence (Cooper et al., 2011; Mead & Bower, 2000; Roter & Larson, 2002) . The unit of analysis is a complete thought communicated as a single word, simple sentence, or a clause in a complex sentence. Statements are coded directly from recordings and assigned to 1 of 37 mutually exclusive code categories. Examples of the RIAS composite codes are published (Guan et al., 2017) and included in the supplementary materials.
Three measures of communication processes were also examined: (1) session length in minutes; (2) the sum of each speaker's (genetic counselor, patient, and visit companion) statements as an indication of total dialog; and (3) patientcenteredness communication, which was operationalized as the ratio of psychosocial and emotional to instrumental exchange. In the current study, the numerator of this latter measure is the sum of patient and companion psychosocial and lifestyle disclosure, questions, emotional statements and active engagement statements, and genetic counselor 808 Y. Guan et al.
psychosocial and lifestyle questions, information and counseling and activation/facilitation statements. The denominator consists of genetic counselors' medical questions and orientations, as well as patient, companion, and genetic counselors' statements relating to medical information. Value greater than 1 indicates a more patient-centered session. A random 10% sample of audiotapes (n = 8) was selected for double coding to establish interrater reliability. Pearson correlation coefficients averaged 0.83 across genetic counselor categories and 0.93 for patient categories, indicating high levels of interrater reliability.
Baseline Measures
Patient and companion characteristics, including age, gender, race, level of education, and caregiver relationship to patient, were assessed by self-report. For the purposes of this study, a family history of AD/dementia was defined as self-report of the number of relatives diagnosed with AD or dementia. General cognitive function of the patient was assessed by the MMSE (Folstein, Folstein, & McHugh, 1975) with possible scores ranging from 0 to 30. A score greater than or equal to 24 typically indicates normal general cognitive function, while 20-23 suggests mild memory problems. APOE genotype was dichotomized to the presence or absence of at least one copy of the APOE ε4 allele, as MCI patients with an ε4 allele are at increased risk of converting to AD compared to patients without an APOE ε4 allele.
Data Analyses
The primary outcomes are high patient and companion satisfaction. The likelihood-ratio tests used to estimate the influence of patient clustering within genetic counselors were not significant; therefore, logistic regressions were used to determine the contribution of each speaker's communication to patient and companion satisfaction (in separate models). To identify potential confounders, adjusted multivariate regression models were generated including patient and companion factors (i.e., patient age, gender, educational level, patient-companion relationship, visit length, MMSE score, 3-year AD risk, and APOE genotype). Patient and companion characteristics found to be statistically significantly (p < 0.05) related to either communication behaviors or satisfaction included patient and companion gender, years of education, and patient 3-year AD risk. These variables were subsequently included as control variables in the final multivariate logistic regression models. Log likelihood chi-squared tests were used to compare the fit of adjusted models against a model that included only the intercept. We asserted statistical significance only in instances where both the overall model and the predictor of interest were significant at p < 0.05. In all analyses, two-tailed tests and p-values <0.05 were used to draw conclusions regarding statistical significance. Data were analyzed using STATA Version 12.0 (STATA Corp, College Station, Texas).
Results
Sample Characteristics
Sample characteristics are presented in Table 1 . Three genetic counselors participated in this study, representing three study sites (Boston, Philadelphia, and Ann Arbor); all the genetic counselors were female Caucasians. The number of patients seen by each genetic counselor was 4, 35, and 40, respectively. The 79 patients comprising our study sample averaged 76 years of age, with the majority of patients being male (56%) and Caucasian (96%). The mean level of education among patients was 16 years. More than half of the patients (N = 49, 62%) have at least one relative diagnosed with AD or dementia. The majority of patients (86%) showed normal cognitive function based on MMSE scores (MMSE ≥24), and 11 patients scored in the range of MCI (MMSE 20-23). The average 3-year risk estimates of progressing to AD provided to all patients were 37% and ranged from 8% to 57%. Of the 54 patients in the genotype disclosure group, 57% (N = 31) carried at least one ε4 allele; 10 (32%) had the ε4/ε4 genotype, and 21 (68%) had the ε3/ε4 genotype. Among those who did not have the ε4 allele (43%, N = 23), 20 had the ε3/ε3 genotype and 3 had the ε2/ε3 genotype. The ε2/ε4 and ε2/ε2 genotypes were not observed in our study. Per study requirement, all patients were accompanied to the session by a family member or friend. Visit companions (N = 79) were on average 68 years of age, predominantly female (70%), and well-educated with an average 16 years of education. They were predominantly spouses (65%) or adult children (24%) with the minority described as "other," including siblings (1%), significant others (2%), and close friends (8%).
Patient and Companion Satisfaction on Interpersonal Communication
Patients and companions in this study were satisfied with the communication of the AD risk disclosure; the average satisfaction scores were 46 (SD = 4, range: 36-50) and 47 (SD = 4, range: 30-50) out of 50 for patients and companions, respectively. In particular, 24% of patients (N = 19) and 48% of companions (N = 38) scored as being highly satisfied with the communication process. The simple observed agreement between patient and companion on high satisfaction was 53%; however, the kappa (0.04, SE = 0.10) indicated only poor to slight agreement when accounting for chance (Landis & Koch, 1977) . Table 2 displays the frequency of statements made by genetic counselors, patients, and companions across the RIAS categories and summarizes the odds ratios from logistic regression models (both unadjusted and adjusted for covariates) to identify communication behaviors that are related to patient and companion satisfaction. The adjusted multivariate logistic regression models include patient and companion gender, years of education, and patient 3-year AD risk.
Communication Behaviors Predicting Patient and Companion Satisfaction
In unadjusted analyses, patients were more often highly satisfied with the AD risk communication when genetic counselors made more positive statements (OR = 1.02, p = 0.04) and when companions asked more psychosocial questions (OR = 1.60, p = 0.03). After adjusting for the covariates, companions' psychosocial question-asking continued to have significant positive association with patient satisfaction (OR = 1.75, p = 0.02); and patient expression of emotion emerged as a significant positive predictor of their high satisfaction (OR = 1.06, p = 0.04).
Companions were less likely to be highly satisfied the more facilitation statements (OR = 0.92, p = 0.046) they made in unadjusted models. In the final adjusted models, companions had almost four times the likelihood of being highly satisfied with the AD risk communication process in sessions with a high patient-centered communication ratio (OR = 3.97, p = 0.048).
Discussion
In general, our findings demonstrate that indicators of patientcentered communication were associated with both patient and companion satisfaction with AD risk disclosure sessions; psychosocially focused questions asked by companions and expression of emotion by patients were associated with greater patient satisfaction, and the summary measure of visit patient-centeredness was predictive of greater companion satisfaction.
We found that patients' active participation in the AD risk communication process positively influenced their satisfaction; when patients expressed emotion (e.g., expressions of reassurance, concern, empathy and legitimization), they were more likely to score as highly satisfied. Prior research has shown that active patient involvement in medical encounters, including emotional and psychosocial disclosure, has been associated with greater satisfaction, as well as other desirable outcomes including increased adherence and positive treatment outcomes (Tennstedt, 2000) . The interactions that occur when these types of disclosures are made can convey therapeutic value, enhance trust, and strengthen the therapeutic alliance between patients and health-care providers (Kennedy-Moore, 2001 ).
Genetic counselors' communication did not play a significant role in affecting patient satisfaction, a relationship that has been seen in other studies . We speculate that feelings of vulnerability associated with mild memory loss may have led patients to depend more on the visit companions during communication between themselves and the counselor, thereby diminishing counselor influence. In our study, patient satisfaction may have been less a function of counselor communication than the cues patients took from their companions' exchanges with the counselor, as suggested by the positive relationship between the number of psychosocial and lifestyle questions that visit companions asked and patient satisfaction. It is also possible that there was simply not enough variation the way counselors communicated results to predict patient satisfaction.
Our findings confirm the important role of the companion's facilitation of visit communication in enhancing patient satisfaction. This finding builds upon prior research that has identified a variety of communication behaviors performed by companions during medical visits that are associated with patient report of satisfaction with care, including asking questions (Wolff & Roter, 2008) . Observational studies and metaanalyses have provided compelling evidence that the presence of a companion is beneficial to the care process: physicians typically provide more information when companions are present than when patients are unaccompanied (Prohaska, 1996) , and the presence of a companion increases patient information recall (Jansen et al., 2010) , participation in medical decision-making (Clayman, Roter, Wissow, & Bandeen-Roche, 2005) , adherence to medical treatments (DiMatteo, 2004) , as well as both patient and physician understanding of one another (Schilling et al., 2002) . The presence of companions may be particularly important when the patient has memory impairments, given the challenges associated with processing complex health information.
We found that the more patient-centered the session was, the greater the likelihood that the companion would be more satisfied with session communication. This result extends previous findings that a higher frequency of patient-centered 810 Y. Guan et al. Questions (psychosocial/lifestyle) behaviors is associated with greater patient satisfaction (Beck, Daughtridge, & Sloane, 2002; Roter DL, 2006; Zachariae et al., 2003) . The discrepancies in satisfaction between patients and companions might be due to their different expectations for the session. Studies have shown that patients and companions almost never show perfect agreement and they are less likely to agree about subjective issues, such as satisfaction with care (Castle, 2005) .
A growing literature has shown that physicians and other health professionals can be taught to understand and implement a variety of patient-centered techniques, including demonstrating empathy, asking for patient understanding, and conveying reassurance (LA et al., 2011) . When working with patients with dementia, communication skills training is particularly important for health professionals and family caregivers (Doyle, 2009) . Systematic reviews in dementia care have demonstrated significant positive effects of communication skills training on professional and family caregivers' communication skills, competencies, and knowledge (Eggenberger, Heimerl, & Bennett, 2013; Wolff et al., 2014) . There is far less literature describing effective strategies for patients with MCI. Our findings provide additional direction and rationale to develop tailored health communication programs for not only physicians and family caregivers but also for patients with mild cognitive deficits, as well.
Some caution is necessary in interpreting our results given the exploratory nature of this study, and the associations found in this descriptive study do not necessarily indicate a causal relation. Satisfaction is a complex construct that may be influenced by unmeasured factors external to the disclosure session communication, and the lack of variance in our satisfaction measure may have limited our ability to detect associations. There is also the possibility that participants may have felt pressure to overstate their satisfaction immediately after the disclosure session. The nonsignificant results could also be due to the small sample size. Furthermore, patients enrolled in the REVEAL trial may differ from a broader population of older adults with mild memory problems considering their high levels of education and motivations to seek genetic testing. Our findings may not apply to other AD risk disclosure sessions, due to the structured nature of the REVEAL protocol and the limited number of genetic counselors that took part in the study.
The positive satisfaction outcomes associated with elements of patient-centered communication support the growing literature and policy attention directed toward delivering family-centered care (Health & Services, 2012) . We also acknowledge the influence of companions in achieving greater patient satisfaction. With the presence and increasing severity of cognitive deficits, the active involvement of companions is critical to facilitate older adults to function successfully in a complex health-care environment. Findings of this study also highlight opportunities for health-care providers, patients, and visit companions to increase effective interactions in AD genetic risk disclosure settings, which may ultimately lead to improved medical care quality and better patient outcomes.
